MEXICAN-AMERICANS (MA) exhibit a two-to threefold excess prevalence of type 2 diabetes mellitus (T2DM) compared with non-Hispanic white (NHW) Americans (60) . Insulin resistance plays a central role in the pathophysiology of T2DM (56) . Studies have shown that, across a wide range of ages, MA males and females both demonstrate greater levels of insulin resistance compared with NHW (1, 5, 30, 64) . Although reasons for this discrepancy are not clear, it has been suggested that genetic factors could explain the higher prevalence of insulin resistance in MA, possibly owing to the fact that up to 35% of their genetic make-up is attributable to Native American ancestry (34) . It is also possible that lifestyle factors, including diet and exercise, contribute to the ethnic differences in insulin resistance. Visceral adiposity (43) , exercise (26) , and dietary fat (51, 63) have all been shown to impact peripheral insulin resistance.
In several previous studies, MA have been shown to exhibit lower insulin sensitivity independently of body fat and body fat patterning (1, 5, 60, 64) . However, this issue is not entirely resolved given that studies that have documented diminished insulin sensitivity in nonobese, nondiabetic MA compared with NHW utilized less sensitive methods [skinfolds, body mass index (BMI), waist-to-hip ratio] to estimate body fat and central adiposity (1, 32, 33) . Furthermore, the possible contribution of lower physical activity and physical fitness in the MA as well as differences in dietary intake were not accounted for in these studies. Because MA compared with NHW tend to exhibit greater central adiposity (31, 61) , are less physically active (14) , and consume a more atherogenic diet (65) , it is important to more carefully examine these factors as possible contributors to the lower insulin sensitivity in MA.
Numerous studies have provided evidence that skeletal muscle insulin resistance seen in T2DM is primarily isolated to the insulin-stimulated phosphatidylinositol 3-kinase (PI3K)-signaling cascade (6, 15) . Under normal physiological conditions, insulin binds to the ␣-subunit of the insulin receptor (IR). This binding activates tyrosine kinase activity in the ␤-subunit and causes tyrosine phosphorylation of various IR substrates (IRS). Once activated, IRS-1 docks with the p85 regulatory subunit of PI3K and activates its p110 catalytic subunit. Catalytic activity of PI3K phosphorylates PI(4,5)P 2 to PI(3,4,5)P 3 . PIP 3 is necessary to activate 3-phosphoinositide-dependent protein kinase-1, which phosphorylates Akt (serine/threonine kinase, a central regulator of anabolic metabolism) on Thr 308 . Subsequent phosphorylation of Akt on Ser 473 further activates the enzyme. Unknown downstream steps enhance the translocation of GLUT4 from intracellular vesicles to the plasma membrane, resulting in glucose entry into the cell. Some studies have documented diminished abundance of some of these proteins in association with insulin resistance, whereas others have not (7, 41, 57, 58) . Despite the well recognized differences in insulin sensitivity between MA and NHW, there are no data available regarding possible differences in the expression of these skeletal musclesignaling proteins, which could account for the lower insulin sensitivity in MA.
We undertook the present study to accomplish two specific aims. First, we sought to determine whether or not differences in insulin sensitivity persist between these two groups after controlling for the effects of acute and chronic exercise, abdominal fat distribution, and dietary intake. Second, we sought to determine whether MA exhibit lower skeletal muscle protein concentrations of IR␤, PI3K p85, Akt1, Akt2, and GLUT4 compared with NHW after controlling for these same potential confounders.
METHODS

Subjects.
A total of 13 nonobese (BMI Ͻ 30) MA (7 females, 6 males) were matched to 13 nonobese NHW (7 females, 6 males) aged 18-40 yr, on the basis of gender, age, and aerobic fitness [maximal O 2 uptake (V O2 max) Յ 5 ml⅐ kg Ϫ1 ⅐ min Ϫ1 ] as measured by a graded exercise test. Subjects were eligible for participation on the basis of the following characteristics: being nonsmoking, apparently healthy individuals with no overt signs or symptoms of disease as determined by a medical history, and having normal fasting blood glucose (Ͻ110 mg/dl), no past or present history of endocrine disorders, and resting blood pressure Ͻ140/90 mmHg. Individuals were excluded from participation for the following reasons: pregnancy, oral contraceptive use, tobacco use, diabetes mellitus, history of any eating disorders, history of menstrual cycle irregularities, history of hypo-or hyperthyroidism, and use of any medications that could influence insulin sensitivity. In addition, subjects had no orthopedic problems that prohibited them from engaging in the maximal-exercise test. Subjects had been weight stable (Ϯ2.5 kg) for the previous 6 mo. To be appropriately identified as MA, each participant traced his/her ethnicity to all four grandparents. The study protocol was approved by the Colorado State University Human Research Committee. Verbal and written informed consent was obtained from each volunteer.
Body mass, height, and composition. Body weight was measured on a balance scale to the nearest 100 g. Body height was measured with a wall-mounted stadiometer to the nearest 0.1 cm. The percentage of body fat, absolute fat mass, and fat-free mass were measured in all subjects by means of dual-energy X-ray absorptiometry using software version 4.5c (model DPX-IQ, Lunar, Madison, WI).
Abdominal visceral fat. The measurement of total, visceral, and subcutaneous fat in the abdominal region was performed using a General Electric high-speed computed tomography (CT) scanner (Milwaukee, WI) with helical capability (21) . A cross-sectional scan 10 mm thick, centered at the L4-L5 intervertebral space, was obtained using 170 mA with a scanning time of 2 s and a 512 ϫ 512 matrix. Abdominal visceral fat (AVF) was measured by sectioning the intraabdominal area by pixel density. Abdominal subcutaneous fat (ASF) was calculated by determining the area of adipose tissue (AT) within the abdominal wall. The areas of deep (DSF) and superficial subcutaneous (SSF) AT were determined by dividing the two compartments on the basis of the fascial delineation (37) . SSF was calculated by subtracting DSF from total subcutaneous AT. Within each of the three compartments, the cross-sectional area of AT was measured in pixels (0.6 mm) in the attenuation range of Ϫ190 to Ϫ30 HU by use of commercially available software (sliceOmatic; Tomovision, Montreal, Canada).
Dietary intake. Subjects were instructed to accurately record food intake (e.g., portion sizes, food preparation methods, brand names of products) over a 4-day period by using two-dimensional food models. Records were checked for completion and sufficiency of detail. Subjects were asked to provide food labels for products used to determine appropriate substitutions when actual items consumed were not in the software database. Food intake records were analyzed using the Food Intake Analysis System (FIAS 3.98 nutrient analysis program, University of Texas School of Public Health, 1998). The FIAS database consists of the Primary Data Set and the Survey Nutrient Data Base of the National Nutrient Data Bank, developed and maintained by the US Department of Agriculture. Two MA, one male and one female, did not complete their 4-day dietary records; thus all analyses conducted involving dietary variables are for 24 subjects only.
Cardiorespiratory fitness. Acute and chronic exercise is related to insulin sensitivity, and MA have been reported to exhibit lower levels of physical activity compared with NHW. Thus we sought to control for this potential confounder by recruiting individuals from both groups who were similar in V O2 max. V O2 max was measured during incremental treadmill exercise to volitional exhaustion as previously described by Balke and Ware (4) . Measurements of oxygen consumption, carbon dioxide production, pulmonary ventilation, and the respiratory exchange ratio were determined by on-line computer-assisted open-circuit spirometry (CPX Express; MedGraphics, Minnesota, MN). To ensure that V O2 max was obtained, at least three of the four following criteria were satisfied: 1) a plateau in oxygen consumption with increasing workload; 2) a respiratory exchange ratio Ն1.15; 3) achievement of 100% of the age-predicted maximal heart rate; and 4) a maximal rating of perceived exertion of Ն18 on the Borg scale.
Insulin sensitivity. For the determination of insulin sensitivity, subjects were instructed to remain fasted for 12 h before blood collection. Furthermore, subjects refrained from participation in any form of exercise for 48 h before the study. Female subjects were tested during the early follicular phase of their menstrual cycles (days 3-10). Four estimates of insulin sensitivity were used: fasting plasma insulin, the homeostatic model assessment of insulin resistance (HOMA-IR) (28) , the quantitative insulin sensitivity check index (QUICKI) (38) , and the revised QUICKI (54) by use of the following formulas HOMA-IR ϭ (fasting insulin, U/ml ϫ fasting glucose, mmol/l)/22.5
where NEFA is nonesterified fatty acid. These estimates have been shown to correlate well with the more direct measures of insulin sensitivity such as the frequently sampled intravenous glucose tolerance test (FSIVGTT) and hyperinsulinemic euglycemic clamp (2, 8, 38, 50).
Muscle biopsies. Muscle biopsies were obtained from all subjects to examine insulin-signaling pathway intermediates and glucose transporters in skeletal muscle. Subjects reported to the laboratory after an overnight fast and 48 h after any exercise. Percutaneous muscle biopsies (Ϸ75 mg) were obtained from the belly of the vastus lateralis by use of a 5-mm Bergstrom needle with suction applied as described previously (36) . Muscle obtained from the subjects was immediately frozen in liquid nitrogen and subsequently analyzed for the determination of IR␤, PI3K p85 ␣/␤-subunits, Akt1, Akt2, and GLUT4 protein abundance.
Immunoblotting. Approximately 50 mg of frozen muscle were homogenized in ice-cold buffer (in mM: 50 HEPES, pH 7.4, 100 NaF, 10 Na 4P2O7, 2.5 EDTA, 2 Na3VO4, and 2 phenylmethylsulfonyl fluoride and 1 M leupeptin, 1 M pepstatin, and 0.2 M aprotinin). Tissue lysates were solubilized with gentle mixing in 1% Triton X-100 for 1.5 h at 4°C and centrifuged at 14,000 g for 15 min at 4°C. Total protein concentration was determined by the bicinchoninic acid assay (Pierce, Rockford, IL). Positive controls (fat cell lysate, Jurkat cell lysate) were used as internal standards for IR␤, PI3K p85␣, Akt1, Akt2, and GLUT4. Data are expressed as protein abundance in arbitrary units, with one group compared relative to the other. Solubilized proteins (50 g) were resolved by 7.5% SDS-PAGE and transferred to a PVDF membrane. The membrane was blocked with 5% nonfat dry milk containing Tris-buffered saline (TBS) containing 0.05% Tween 20 for 1 h at room temperature. The membrane was then incubated with 3% milk for 1 h in TBS containing 0.05% Tween 20 at room temperature with antibodies to IR␤ and Akt1 from Upstate Biotechnology, (Lake Placid, NY), PI3K p85␣/␤, Akt2, and GLUT4. Anti-p85 antibodies were raised by Rockland (Gilbertsville, PA) against a protein in which glutathione S-transferase (GST) is fused to the NH 2-terminal SH2 domain of p85, kindly provided by Jonathan Backer (Albert Einstein College of Medicine). Polyclonal rabbit antiAkt2 antibodies were raised against the COOH-terminal sequence CDQTHFPQFSYSASIRE in Akt2. Polyclonal sheep anti-GLUT4 antibodies were raised against a GST fusion protein containing the last 31 amino acids of the GLUT4 COOH terminus (GST-ISATFRRTPSLLEQEVKPSTELEY-LGPDEND). Membranes were incubated with the horseradish peroxidase-conjugated secondary antibody for 1 h at room temperature and then washed with TBS containing 0.05% Tween 20. The bands were visualized using the Enhanced Chemiluminescence Plus System (Amersham, Arlingtom Heights, IL) and quantified by phosphoimager.
Assays. Blood glucose was measured by the glucose oxidase method with an autoanalyzer (YSI 2300 Stat Plus, Yellow Springs Instrument, Yellow Springs, OH). Plasma insulin was measured using a two-step sandwich ELISA (DSL, Webster, TX). This assay demonstrates a 2.6% intra-assay and 6.2% interassay variation. Total plasma NEFA concentrations were analyzed by colorimetric assay (Waco Chemicals, Richmond, VA).
Statistical analysis. Data were analyzed for normality and homogeneity of variance. Dependent variables were initially subjected to normal testing by use of both qualitative (data plots) and quantitative (Kolmogorov-Smirnov test) approaches. Group differences were analyzed using a 2 ϫ 2 ANOVA (ethnicity ϫ gender). When gender differences failed to reach significance, males and females were analyzed together within ethnic groups by independent t-tests. Pearson product-moment correlations and partial correlations were used to determine associations between independent and dependent variables. Analysis of covariance was performed when potentially confounding variables exhibited a significant relationship to the dependent variables. The significance level was set a priori at P Ͻ 0.05.
RESULTS
Subject characteristics are given in Table 1 . On average, both groups were composed of young, normalweight men and women of moderate cardiorespiratory fitness. There were expected gender differences in several of the physical characteristics such as height, weight, body composition, fat patterning, and V O 2 max . However, there were no ethnic differences in any of these physical characteristics, except for the lower stature of MA compared with NHW. CT revealed that total AVF, total ASF, SSF, and DSF were not different between the two groups ( Table 1) . The MA exhibited a Dietary intake of energy and macronutrients is shown in Table 2 . Percent total energy intake from palmitoleic acid was significantly higher among MA, with a trend toward higher percent total energy intake from palmitic acid and oleic acid and lower fiber intake among MA (Table 2) . After gender was co-varied for, total intake of palmitic acid was significantly higher among MA (11.39 Ϯ 1.53 vs. 15.74 Ϯ 2.07 g/day, P Ͻ 0.05). Table 3 provides information on indexes of insulin sensitivity and plasma NEFA. HOMA-IR was significantly higher, and the revised QUICKI was significantly lower, among MA compared with NHW subjects, indicating lower insulin sensitivity in the former group. Group differences in fasting glucose (P ϭ 0.11), insulin (P ϭ 0.07), and QUICKI (P ϭ 0.06) approached statistical significance. Although the higher plasma NEFA concentration in the MA compared with the NHW subjects was not statistically significant, it also approached significance (P ϭ 0.09).
Despite the possible confounding factors shown in Table 1 (i.e., fitness and fatness) being taken into account, differences in insulin sensitivity between MA and NHW subjects persisted. Differences in HOMA-IR between the groups remained significant after percent intakes of total fat, saturated fat, and all fatty acids except for palmitate and palmitoleate were accounted for. Differences in HOMA-IR between the groups lost significance when percent energy intake from palmitic acid, percent energy intake from palmitoleic acid, or protein abundance of IR␤ was accounted for. Correlations between HOMA-IR and these covariates are shown in Fig. 1 .
Representative immunoblots are shown in Fig. 2 . There were no significant differences between the two groups with regard to skeletal muscle protein abundance of IR␤, PI3K p85, Akt1, Akt2, or GLUT4 (Fig. 3) . Skeletal muscle protein abundance of IR␤ was significantly associated with fasting plasma insulin (r ϭ Ϫ0.46, P Ͻ 0.05) and HOMA-IR (r ϭ Ϫ0.43, P Ͻ 0.05). Skeletal muscle Akt2 protein levels were associated with HOMA-IR after gender was accounted for, although this relationship did not reach statistical significance (r ϭ Ϫ0.37, P ϭ 0.07). Abundance of the other signaling proteins studied was not related to estimates of insulin sensitivity.
Pearson product-moment correlations were used to analyze relationships between estimates of insulin sensitivity and dietary variables (Table 4) . When the groups were analyzed in aggregate, fasting insulin was positively associated with percent energy intake from fat (r ϭ 0.43, P Ͻ 0.05) and percent energy intake from monounsaturated fat and inversely associated with fiber intake. The degree of insulin resistance estimated by HOMA-IR was associated with percent energy intake from fat, percent energy intake from monounsaturated fat, and percent energy intake from saturated fat. HOMA-IR was significantly associated with the intake of individual fatty acids, palmitate, stearate, palmitoleate, and oleate. HOMA-IR was also associated with percent energy intake from carbohydrate and fiber intake. Correlations of these dietary variables with QUICKI and revised QUICKI were of similar magnitude to the correlations with HOMA-IR.
Pearson product-moment correlations were used to analyze relationships among insulin sensitivity, adiposity measures, plasma NEFA, and cardiorespiratory fitness. Indexes of insulin sensitivity (fasting insulin, HOMA-IR) were not related to BMI, percent body fat, AVF, ASF, SSF, or DSF (not shown). Fasting plasma NEFA concentrations were not related to fasting insulin or HOMA-IR. Fasting plasma NEFA was significantly associated with both fasting glucose (r ϭ 0.49, P Ͻ 0.05) and percent total calories from fat (r ϭ 0.44, P Ͻ 0.05). Among the entire sample, cardiorespiratory fitness expressed as maximal metabolic equivalents (maximal exercise V O 2 relative to resting V O 2 , i.e., multiples of resting metabolic rate) was associated with indexes of insulin sensitivity (HOMA-IR: r ϭ 0.48, P Ͻ 0.02; fasting insulin: r ϭ 0.49, P Ͻ 0.02) and IR␤ (r ϭ 0.43, P Ͻ 0.05).
DISCUSSION
There are several important findings from this study that warrant discussion. First, nonobese, nondiabetic MA adults were less insulin sensitive compared with NHW adults, even when the potential roles of cardiorespiratory fitness, acute exercise, and total and regional adiposity were accounted for. Second, skeletal muscle protein abundance of IR␤, PI3K p85, Akt1, Akt2, and GLUT4 was not significantly different between the two groups and therefore does not account for the group differences in insulin sensitivity. Finally, group differences in insulin sensitivity were attenuated to losing statistical significance after dietary intakes of palmitic acid, palmitoleic acid or skeletal muscle IR␤ protein content were accounted for.
The results of our study extend previous findings in several important areas. Previous studies used crude anthropometric methods (BMI, skinfolds) to measure body adiposity (30, 60) , whereas the present data suggest that differences in insulin sensitivity between nonobese, nondiabetic MA and NHW persist after both total adiposity and abdominal adiposity determined by CT are accounted for. It has recently been suggested that fat stored in various abdominal compartments (visceral vs. subcutaneous) confers different degrees of association with insulin resistance (39) . Abdominal obesity is widely recognized as a strong correlate of insulin resistance. Visceral adiposity, independent of total adiposity, has been implicated in the etiology of skeletal muscle insulin resistance and T2DM (17, 27) . Recently, it has been reported that both abdominal visceral adiposity and deep subcutaneous adiposity are strongly associated with peripheral insulin resistance, whereas superficial abdominal fat is not (39) . The use of CT in the present study allowed us to characterize these specific aspects of fat patterning rather than using less accurate measures of fat patterning such as skinfold thickness, waist circumference, or waist-tohip ratios. Why, then, given the use of the gold standard, was the magnitude of visceral adiposity not associated with the measures of insulin sensitivity in our study? One possible explanation is that, because all subjects were nonobese, the lack of adequate heterogeneity in both abdominal fat and insulin sensitivity may have masked a relationship. Nevertheless, it is evident that, even within a homogeneous sample, nonobese MA are less insulin sensitive than NHW, with this difference apparently unrelated to visceral adiposity.
Dietary fat has been considered to be a risk factor in the development of insulin resistance and T2DM (51), but many studies have failed to account for the higher intake of dietary fat commonly reported among MA. Here, we have shown that MA exhibit a tendency to consume higher amounts of dietary fat, which, from a statistical analysis approach, partially mediate differences in insulin sensitivity compared with NHW. Our findings are in agreement with numerous studies showing that high dietary fat and saturated fat intake is associated with reduced insulin sensitivity (10, 48, 49) . MA children exhibiting a greater degree of insulin resistance compared with NHW have been reported to consume higher than recommended percent energy from fat and saturated fat (65, 67) . There was a trend for MA in our study to ingest more total and saturated fatty acids than NHW, with differences reaching statistical significance for palmitate and palmitoleate. Previous reports have shown an inverse relationship between insulin sensitivity and the dietary intake of palmitate and palmitoleate (66) . Presumably, dietary intake of palmitate and palmitoleate affects the concentrations of these fatty acids in plasma and muscle and may result in decreased insulin sensitivity. Interestingly, as has been documented in large, heterogeneous epidemiological studies, we were able to observe significantly lower insulin sensitivity coupled with higher dietary fat intake among our group of young, nonobese, nondiabetic MA compared with NHW individuals. Together, these data suggest the possibility that the slight yet significantly higher intake of specific dietary fatty acids among MA may contribute to their lower insulin sensitivity.
It has been clearly established that exercise improves insulin action in skeletal muscle (18, 26, 35) .
These improvements are typically observed within the first 24 h after an exercise bout (19, 42, 68) . Some studies have suggested that chronic exercise training is also associated with improved insulin responsiveness (52, 59) . A recent study found that cardiorespiratory fitness levels (V O 2 max ) were associated with fasting insulin concentrations after age, percent body fat, and waist circumference were controlled for (44) . Similarly, we found a significant inverse relationship between cardiorespiratory fitness and HOMA-IR in our entire sample after controlling for gender, body fat, and total abdominal fat (data not shown). Despite the effect of exercise on insulin action, some previous studies in MA have neglected to account for the possible influences of acute and chronic exercise on estimates of insulin sensitivity (1, 30) . We hypothesized that, when any confounding effects of acute exercise (by eliminating all exercise for 48 h before blood sampling) and matching MA and NHW for cardiorespiratory fitness were controlled for, there would be no decrement in insulin sensitivity in MA. However, our data indicate that the lower insulin sensitivity in MA persists even when fitness and acute exercise are rigorously controlled for.
We were also interested in examining whether or not nonobese, nondiabetic MA displayed differences in several of the main proteins involved in the PI3K insulinsignaling pathway. Although insulin receptor numbers have been shown to be significantly decreased in isolated adipocytes from obese T2DM patients (57), the number has been shown to be only slightly reduced in skeletal muscle of these individuals (11) . One study found that protein levels of PI3K were lower in diabetic vs. nondiabetic mice (7), whereas Andreelli et al. (3) found that mRNA levels of IRS-1, PI3K p85␣, and GLUT4 were not different in skeletal muscle of controls and T2DM patients. Another study reported that the amount of Akt2 in skeletal muscle of obese rats was 56% lower compared with lean rats but that there were no differences in the amount of IR or the p85 regulatory subunit of PI3K in insulin-resistant vs. control skeletal muscle (20) . Kim et al. (41) found no differences in the amount of Akt1 between insulin-resistant obese and lean rats. Although diabetic individuals exhibit impaired Akt activity, no differences in Akt pro- tein levels between healthy volunteers and type 2 diabetics have been documented (12, 46) . Several studies have documented a reduction in GLUT4 expression in isolated adipocytes (47, 58) and skeletal muscle (25) of patients with T2DM. However, other studies have failed to show reduced GLUT4 expression in skeletal muscle of T2DM patients (13, 23, 53) . One study has reported that GLUT4 density is lower in slow-twitch skeletal muscle fibers of T2DM individuals (24) . In the present study, we found that, in the entire sample, estimates of insulin sensitivity were related to IR␤ and Akt2 protein abundance. However, the lack of group differences in signaling proteins suggests that the lower insulin sensitivity in MA is not the result of reduced skeletal muscle expression of IR␤, PI3K p85, Akt1, Akt2, or GLUT4.
We can only speculate on the mechanisms responsible for the lower insulin sensitivity in MA compared with NHW in the present investigation. Although we documented a tendency for MA to consume higher intakes of dietary fat compared with NHW individuals, we did not determine plasma fatty acid or intramuscular lipid profiles in these subjects. Palmitate is one of the least preferred substrates for skeletal muscle ␤-oxidation (16) and has been implicated in the de novo synthesis of ceramide, a known inhibitor of insulinstimulated glucose uptake (62) . The possible relation of fatty acid intake, plasma fatty acids, intramuscular lipid, ceramide production, and insulin sensitivity should be addressed in future studies of MA.
There are some potential limitations of the present study that should be addressed. First, we used only fasting samples of glucose and insulin to determine surrogates of insulin sensitivity (i.e., HOMA-IR, QUICKI, and revised QUICKI) rather than the more clinically sophisticated FSIGTT or the hyperinsulinemic euglycemic clamp. The reasons we used this approach are as follows. Strong associations between these estimates and the hyperinsulinemic euglycemic clamp technique have been found in several studies (2, 8, 38) . Haffner et al. (29) have previously shown the HOMA-IR method to be able to readily characterize the lower insulin sensitivity in MA compared with NHW. Furthermore, it has been suggested that estimates of insulin sensitivity based on fasting insulin and glucose may be the best markers of early insulin resistance in nondiabetic individuals (22, 47) . Thus this approach seemed especially well suited for the study of young, nonobese, nondiabetic MA individuals, all of whom exhibited fasting blood glucose concentrations Ͻ110 mg/dl. Note that, although the MA subjects were less insulin sensitive on the basis of HOMA-IR and revised QUICKI, they are clearly not to be considered "insulin resistant." However, previous studies have implicated diminished insulin sensitivity among nondiabetic MA as a risk factor for future insulin resistance and development of T2DM (5, 30) . Another limitation is the use of self-reported dietary intake records to characterize habitual intake of energy and macronutrients. Although such dietary assessment has inherent inaccuracies, we took painstaking efforts to accurately estimate serving sizes and used a research dietitian to review recorded information with each study subject. The fact that the group differences in insulin sensitivity were found and were statistically related to dietary fat intake, even in the face of less than perfect estimates of insulin sensitivity and dietary intake, suggests that this may be a very important finding. An obvious extension of this study will be to experimentally determine whether manipulations of dietary fatty acids in MA affect insulin action.
Longitudinal data are not available regarding the quantitative importance of dietary habits with respect to genetic background exhibited by MA. However, studies of this nature have been conducted with Pima Indians (9, 55), which may be relevant considering that up to 35% of the genetic background of MA is attributable to Native American ancestry (34) . Pima Indians maintaining a traditional lifestyle (lower fat, high intake of low glycemic index carbohydrates) in Mexico are typically nonobese and exhibit a low prevalence of diabetes (55) . On the other hand, Pimas living in Ari- zona who have adapted to a more Western lifestyle (higher dietary fat, higher glycemic index carbohydrates) are more obese and insulin resistant (55) . One might speculate that slightly higher dietary fat intakes exhibited by the MA in our study could be quantitatively important, particularly if coupled with differences in fat oxidation, which could impact intramuscular fat accumulation. The lack of group differences in skeletal muscle cytosolic insulin-signaling proteins is a novel finding. However, we did not evaluate functional activity or insulin-stimulated phosphorylation of these intermediates. Clinical states of insulin resistance have been associated with impairments in insulin-stimulated glucose uptake and are associated with decreases in IRS-1 tyrosine phosphorylation, PI3K activity, and Akt serine/threonine phosphorylation. Kim et al. (40) and others (6, 25, 45) have reported that insulin-stimulated IRS-1-associated PI3K activity is decreased in skeletal muscle of diabetic subjects. Although impaired activities of these proteins appear to be primary defects in insulin-stimulated GLUT4 translocation, reduced protein content may contribute to some models of human insulin resistance. Additionally, a growing body of evidence suggests that other mediators of insulin responsiveness (PKC, IKK␤) may be involved in skeletal muscle insulin resistance. Future studies should investigate possible differences in basal and insulin-stimulated activity of these signaling intermediates.
In summary, the present study demonstrates that lower insulin sensitivity persists in nonobese, nondiabetic Mexican-Americans compared with their nonHispanic white counterparts, even after acute and chronic effects of exercise and abdominal fat distribution are accounted for. Furthermore, these differences are not explained by the protein abundance of skeletal muscle IR␤, PI3K p85, Akt1, Akt2, or GLUT4. Differences in insulin sensitivity are lost when dietary intakes of palmitate and palmitoleate are accounted for, suggesting the possibility that these factors may contribute to the lower insulin sensitivity seen in MexicanAmericans. Future studies should determine whether this relationship is coincidental or causal.
